Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter, Uncontrolled, Rater-blinded, Post-market Clinical Follow-up [PMCF] Study to Confirm Performance and Safety of RADIESSE® (+) Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines, and/or Cheek Volume Loss

NCT03650387 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT03650387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter, Uncontrolled, Rater-blinded, Post-market Clinical Follow-up [PMCF] Study to Confirm Performance and Safety of RADIESSE® (+) Lidocaine in the Treatment of Nasolabial Folds, Marionette Lines, and/or Cheek Volume Loss
Lead sponsor
Merz North America, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 17, 2018
Completion date
May 26, 2020
Enrollment
207 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

signs of facial aging with volume loss in the upper cheeks, nasolabial folds and marionette lines